海外の治験の状況「前立腺癌」での検索結果
118件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- ARI103094-Follow-Up Study for REDUCE Study Subjects
- Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate
- Argentina, Canada, Chile, Finland, France, Germany, Greece, Netherlands, Spain, Sweden, United Kingdom, United States
- 2009-04-16
Not Recruiting
- A Study of JNJ-56021927 Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants with Low-Volume mHSPC
- Prostate Cancer; Prostatic Neoplasm; Mlignant Neoplasm of Prostate C04.588.945.440.770 C61;C00-D48;C04.588.945.440.770
- Argentina, Australia, Brazil, Canada, Czech Republic, Democratic Republic Lau, France, Germany, Mexico, Romania, Spain, Turkey, Ukraine, United Kingdom
- 2016-04-01
Not recruiting
- Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations
- Prostatic Neoplasms
- Brazil
- 2013-09-25
Not recruiting
- A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
- Prostate Cancer
- Argentina, Australia, Brazil, Canada, China, Czech Republic, Czechia, France, Germany, Hungary, Israel, Japan, Korea, Republic of, Mexico, Poland, Romania, Russian Federation, Spain, Sweden, Turkey, Ukraine, United Kingdom, United States
- 2015-07-01
Not Recruiting
- A Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated With Docetaxel/ Prednisone for Metastatic Androgen-independent Prostate Cancer
- Prostatic Neoplasms # Neoplasm Metastasis;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Netherlands, Poland, Portugal, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Province of China, Turkey, Ukraine, United Kingdom, United States
- 2012-04-30
Not Recruiting
- A Randomized, Open Label Multi-Center Study of XRP6258 at 25 mg/m^2 in Combination With Prednisone Every 3 Weeks Compared to Mitoxantrone in Combination With Prednisone For The Treatment of Hormone Refractory Metastatic Prostate Cancer Previously Treated With A Taxotere®-Containing Regimen
- Neoplasms # Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Argentina, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Province of China, Turkey, United Kingdom, United States
- 2015-11-12
Not recruiting
- Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial
- Prostate Cancer;Urologic Diseases;Prostate Cancer;Urologic Diseases;Prostate Cancer;Urologic Diseases;Prostate Cancer;Urologic Diseases
- Brazil
- 2013-01-03
Not Recruiting
- Randomized, Open Label, Multi-Center Study Comparing Cabazitaxel at 25 mg/m2 and at 20 mg/m² in Combination With Prednisone Every 3 Weeks to Docetaxel in Combination With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Not Pretreated With Chemotherapy
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Belarus, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Taiwan, Province of China, Turkey, Ukraine, United States
- 2015-01-09
Not Recruiting
- A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Israel, Italy, Korea, Republic of, Peru, Poland, Portugal, Slovakia, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
- 2015-11-13
Not Recruiting
- A Multicenter, Open-Label, Randomized, Phase III Trial Comparing Immediate Adjuvant Hormonal Therapy (ELIGARD®- Leuprolide Acetate) in Combination With TAXOTERE® (Docetaxel) Administered Every Three Weeks Versus Hormonal Therapy Alone Versus Deferred Therapy Followed by the Same Therapeutic Options in Patients With Prostate Cancer at High Risk of Relapse After Radical Prostatectomy
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Australia, Austria, Brazil, Canada, France, Germany, India, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, South Africa, Turkey, United Kingdom, United States
- 2015-11-11